Insight Molecular Diagnostics (IMDX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 11, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials online and may request paper or email copies at no charge.

Voting matters and shareholder proposals

• Election of four director nominees to serve until the 2027 annual meeting or until successors are elected.

• Ratification of CBIZ CPAS P.C. as independent auditor for the year ending December 31, 2026.

• Advisory vote on named executive officer compensation for the year ended December 31, 2025.

• Approval of an amendment to increase shares authorized under the 2018 Equity Incentive Plan by 1,750,000, totaling 5,550,000 shares.

• Board recommends voting "FOR" all director nominees and proposals 2, 3, and 4.

Board of directors and corporate governance

• Four director nominees: Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E. Silverman.

• Directors to serve until the 2027 annual meeting or until successors are elected and qualified.